Antibody to Fungal and Related Antigens
ACCREDITATION STATUS:
UKAS accredited proficiency testing provider No. 7795
CLINICAL APPLICATION:
Diagnosis and monitoring of Extrinsic Allergic Alveolitis and Type III hypersensitivity diseases including Aspergillus and Candida infections, Bird Fancier's and Farmer's Lung
PURPOSE OF PROGRAMME:
Allergy and Immunodeficiency EQA scheme
ANALYTES:
Analyte | Default Unit |
---|---|
Aspergillus Fumigatus | Qualitative and quantitative responses |
Avian Antibodies | |
Budgerigar Droppings | Qualitative and quantitative responses |
Budgerigar Feathers | Qualitative and quantitative responses |
Budgerigar Mix and Micropolyspora Faeni | Qualitative and quantitative responses |
Budgerigar Serum | Qualitative and quantitative responses |
Candida Albicans | Qualitative and quantitative responses |
Pigeon Droppings | Qualitative and quantitative responses |
Pigeon Feathers | Qualitative and quantitative responses |
Pigeon Mix | Qualitative and quantitative responses |
Pigeon Serum | Qualitative and quantitative responses |
MATERIAL PROVIDED: Liquid format. Normal and pathological human serum
DISTRIBUTIONS PER YEAR: 6
SAMPLES PER DISTRIBUTION: 2
FREQUENCY OF DISTRIBUTION: Every two months as outlined in the Distribution Schedule
PROGRAMME OF ANALYSIS:
Data entry is via the web for the submission of results. Data analysis is commenced 21 days after sample dispatch. Late returns are accepted and will contribute to the laboratory's cumulative performance statistics
DATA ANALYSIS:
Qualitative results are assessed by Misclassification Index Scoring in relation to a Designated Response
PERFORMANCE SCORING:
MI scoring
PERFORMANCE MONITORING:
Laboratory performance is classified in terms of OMIS derived from the qualitative responses for all analytes for which the laboratory is registered during a running analytical window of 6 Distributions (12 months). An MIS of 3 or more for a single analyte is also classified as being of poor performance
PERSISTENT POOR PERFORMANCE:
Defined as being in the Poor Performance category for two or more successive distributions
Immunology, Immunochemistry & Allergy (IIA)
The External Quality Assessment Scheme for Immunology, Immunochemistry & Allergy (IIA) was founded in 1982 by Dr Anthony Milford Ward at Northern General Hospital, Sheffield. In 1982 the Service became known as the UK National External Quality Assessment Service for Immunology, Immunochemistry & Allergy. UK NEQAS IIA is part of the Sheffield Teaching Hospitals NHS Foundation Trust. For the most up-to-date scheme information (including any pilot schemes) please contact the centre directly.
Contact Details
- UK NEQAS Immunology, Immunochemistry & Allergy
- Sheffield Teaching Hospitals NHS Foundation Trust
- PO Box 894
- Sheffield
- S5 7YT
Immunology, Immunochemistry & Allergy (IIA)
- Telephone: +44 (0) 114 271 5715
- Email: ukneqas@immqas.org.uk
- Web: https://www.immqas.org.uk/